BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$82.5

Market cap

$12.5B

P/E Ratio

62.03

Dividend/share

$0.16

EPS

$1.33

Enterprise value

$12.63B

Highlights
The net income is up by 29% since the previous quarter and by 15% year-on-year
BRKR's EPS is up by 29% since the previous quarter and by 17% year-on-year
BRKR's price to earnings (P/E) is 59% higher than its 5-year quarterly average of 39.1 and 39% higher than its last 4 quarters average of 44.5
The quick ratio has decreased by 26% YoY and by 16% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.bruker.com/
Peers: PKI TMO WAT BIO

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
151.52M
Market cap
$12.5B
Enterprise value
$12.63B
Valuations
Price to earnings (P/E)
62.03
Price to book (P/B)
12.92
Price to sales (P/S)
5.91
EV/EBIT
43.1
EV/EBITDA
33.52
EV/Sales
5.96
Earnings
Revenue
$2.12B
EBIT
$293M
EBITDA
$376.7M
Free cash flow
$305.2M
Per share
EPS
$1.33
Free cash flow per share
$2.01
Book value per share
$6.38
Revenue per share
$13.95
TBVPS
$16.52
Balance sheet
Total assets
$3.03B
Total liabilities
$2.05B
Debt
$824.2M
Equity
$967.7M
Working capital
$1B
Liquidity
Debt to equity
0.85
Current ratio
2.06
Quick ratio
1.14
Net debt/EBITDA
0.34
Margins
EBITDA margin
17.8%
Gross margin
48.4%
Net margin
9.6%
Operating margin
15.2%
Efficiency
Return on assets
6.9%
Return on equity
21.6%
Return on invested capital
15.9%
Return on capital employed
14%
Return on sales
13.8%
Dividend
Dividend yield
0.19%
DPS
$0.16
Payout ratio
12%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
0.3%
1 week
2.03%
1 month
6.37%
1 year
84.89%
YTD
52.41%
QTD
8.58%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$2.12B
Gross profit
$1.03B
Operating income
$321M
Net income
$204M
Gross margin
48.4%
Net margin
9.6%
The net income is up by 29% since the previous quarter and by 15% year-on-year
BRKR's operating income is up by 29% since the previous quarter and by 17% year-on-year
Bruker's net margin has increased by 22% from the previous quarter and by 10% YoY
BRKR's operating margin is up by 22% QoQ and by 13% YoY

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
62.03
P/B
12.92
P/S
5.91
EV/EBIT
43.1
EV/EBITDA
33.52
EV/Sales
5.96
BRKR's price to earnings (P/E) is 59% higher than its 5-year quarterly average of 39.1 and 39% higher than its last 4 quarters average of 44.5
BRKR's EPS is up by 29% since the previous quarter and by 17% year-on-year
The stock's price to book (P/B) is 90% more than its 5-year quarterly average of 6.8 and 62% more than its last 4 quarters average of 8.0
BRKR's equity is up by 6% YoY
The stock's price to sales (P/S) is 97% more than its 5-year quarterly average of 3.0 and 56% more than its last 4 quarters average of 3.8
Bruker's revenue has increased by 7% QoQ and by 4.1% YoY

Efficiency

How efficient is Bruker business performance
Bruker's return on invested capital has increased by 35% QoQ
BRKR's return on assets is up by 30% since the previous quarter
Bruker's return on equity has increased by 28% QoQ and by 7% YoY
BRKR's return on sales is up by 23% since the previous quarter and by 10% year-on-year

Dividends

What is BRKR's dividend history
DPS
$0.16
Dividend yield
0.19%
Payout ratio
12%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 48% greater than its total liabilities
The quick ratio has decreased by 26% YoY and by 16% from the previous quarter
BRKR's current ratio is down by 21% year-on-year and by 15% since the previous quarter
Bruker's debt is 15% less than its equity
BRKR's debt to equity is down by 26% year-on-year and by 3.4% since the previous quarter
Bruker's debt has decreased by 22% YoY and by 2.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.